Assessment by a New ELISA Method of Clinical Relevance of Serum Concentration of Adipocyte Fatty Acid Binding Protein in Patients with Metabolic Syndrome Diagnosis

Page: 1116

D. Stejskala, M. Karpíšekb, and P. Kollárb

aDepartment of Laboratory Medicine, Hospital, Šternberk, bFaculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno


Development, composition, validation and clinical relevance of the first ELISA method for measurement of adipocyte fatty acid binding protein (A-FABP) concentration in serum is presented. First results of clinical testing confirm the hypothesis on the possible use of A-FABP as a marker of metabolic syndrome.


Full text (PDF)